PRSS50 and breast carcinoma: In summary, TSP50 and p85α competitively bind with p110α, which increases the catalytic activity of p110α to enhance PI3K/AKT signal transduction, thereby promoting CSC-like properties and EMT, which is beneficial for the migration and invasion of breast cancer cells.